Onyx Pharmaceuticals, Inc. And Bayer Corporation Drug Gets Fast Track For Liver Cancer

BOSTON, June 13 (Reuters) - A kidney cancer drug made by Onyx Pharmaceuticals Inc. (ONXX.O: Quote, Profile, Research) and Bayer Pharmaceuticals Corp. (BAYG.DE: Quote, Profile, Research) will be reviewed on a speedy basis by U.S. regulators as a potential treatment for liver cancer, the companies said on Tuesday.

Back to news